Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment Journal of Medicinal Chemistry You thought Ozempic was big? Just wait. The next generation of weight loss medications is already in clinical trials oral pills, monthly injections, and even triple action drugs that may work better than Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management Alhomoud 2024 Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Wiley Online Library Novo's Phase 3 CagriSema results disappoint analysts, sending stock tumbling MM+M Medical Marketing and Media Glucagon Like Peptide 1 Based Therapies: A New Horizon in Obesity Management